Výsledky vyhledávání - "Douis, Hassan"

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

Autor: Parker, Chris C., James, Nicholas D., Brawley, Christopher D., Clarke, Noel W., Ali, Adnan, Amos, Claire L., Attard, Gerhardt, Chowdhury, Simon, Cook, Adrian, Cross, William, Dearnaley, David P., Douis, Hassan, Gilbert, Duncan C., Gilson, Clare, Gillessen, Silke, Hoyle, Alex, Jones, Rob J., Langley, Ruth E., Malik, Zafar I., Mason, Malcolm D., Matheson, David, Millman, Robin, Rauchenberger, Mary, Rush, Hannah, Russell, J. Martin, Sweeney, Hannah, Bahl, Amit, Birtle, Alison, Capaldi, Lisa, Din, Omar, Ford, Daniel, Gale, Joanna, Henry, Ann, Hoskin, Peter, Kagzi, Mohammed, Lydon, Anna, O’Sullivan, Joe M., Paisey, Sangeeta A., Parikh, Omi, Pudney, Delia, Ramani, Vijay, Robson, Peter, Srihari, Narayanan Nair, Tanguay, Jacob, Parmar, Mahesh K. B., Sydes, Matthew R., for the STAMPEDE Trial Collaborative Group

Publikováno v: STAMPEDE Trial Collaborative Group, Parker, C C, James, N D, Brawley, C D, Clarke, N W, Ali, A, Amos, C L, Attard, G, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D C, Gilson, C, Gillessen, S, Hoyle, A, Jones, R J, Langley, R E, Malik, Z I, Mason, M D, Matheson, D, Millman, R, Rauchenberger, M, Rush, H, Russell, J M, Sweeney, H, Bahl, A, Birtle, A, Capaldi, L, Din, O, Ford, D, Gale, J, Henry, A, Hoskin, P, Kagzi, M, Lydon, A, O'Sullivan, J M, Paisey, S A, Parikh, O, Pudney, D, Ramani, V, Robson, P, Srihari, N N, Tanguay, J, Parmar, M K B & Sydes, M R 2022, ' Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial ', PLoS Medicine, vol. 19, no. 6, e1003998 . https://doi.org/10.1371/journal.pmed.1003998

BackgroundSTAMPEDE has previously reported that radiotherapy (RT) to the prostate improved overall survival (OS) for patients with newly diagnosed prostate cancer with low metastatic burden, but not those with high-burden disease. In this final analy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7eed042b139f7c5cd966c1b7b63924c
https://orca.cardiff.ac.uk/id/eprint/150285/2/pmed.1003998.pdf

Zobrazit plný text záznamu

850PD - Benefit of prostate radiotherapy for patients with lymph node only or < 4 bone metastasis and no visceral metastases: Exploratory analyses of metastatic site and number in the STAMPEDE 'M1|RT comparison'

Autor: Ali, Adnan, Hoyle, Alex, James, Nicholas D, Parker, Christopher C, Brawley, Christopher D, Attard, Gerhardt, Douis, Hassan, Mason, Malcolm D, Parmar, Mahesh K B, Sydes, Matthew R., Clarke, Noel

Publikováno v: Ali, A, Hoyle, A, James, N D, Parker, C C, Brawley, C D, Attard, G, Douis, H, Mason, M D, Parmar, M K B, Sydes, M R & Clarke, N 2019, ' 850PD-Benefit of prostate radiotherapy for patients with lymph node only or < 4 bone metastasis and no visceral metastases: Exploratory analyses of metastatic site and number in the STAMPEDE “M1|RT comparison” ', Annals of Oncology, pp. v330 . https://doi.org/10.1093/annonc/mdz248.007

Background Prostate radiotherapy (PRT) with androgen deprivation therapy (ADT) is now recommended as a first line option for de-novo low burden metastatic prostate cancer. In the STAMPEDE “M1|RT comparison” metastatic burden was a determinant of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3818::10798e6f0bdbcc073c5340707b4727ae
https://doi.org/10.1093/annonc/mdz248.007

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání